New section

Content Background

New section

340B Guidance Withdrawn from OMB

February 3, 2017

New section

New section

PRESS CONTACTS
Mary Mullaney, Director, Hospital Payment Policies

The Office of Management and Budget (OMB) Jan. 30 withdrew the 340B Drug Pricing Program guidance from review. The 340B guidance was one of three documents withdrawn as a result of the memorandum issued by the administration freezing the review of all regulations and guidance [see Washington Highlights, Jan. 27].

The 340B Program, administered by the Health Resources and Services Administration (HRSA), allows certain safety net hospitals to purchase outpatient drugs at a discount from drug manufacturers and use the savings to expand care services to vulnerable populations. It is unclear if the guidance will be re-submitted for review at a later date.

The AAMC provided comments on the proposed guidance during its comment period in 2015 [see Washington Highlights, Oct. 30, 2015].

New section